Why Sepsis Still Gets Missed and How Prenosis Is Narrowing the Signal

Sepsis has been on hospital priority lists for years, yet it still slips past clinicians every day. The challenge is not awareness. It is variability, speed, and too many signals competing for attention.

In this conversation, Robin Carver, Senior Vice President of Commercialization at Prenosis, explains why sepsis is so hard to diagnose early and how a more precise, biologically grounded approach is changing the conversation. She shares why broad alerts often fail, how individual immune response plays a critical role, and what narrowly focused, FDA-authorized AI can realistically add to clinical decision making.

How do you reduce noise without missing risk? And what does “augmented intelligence” actually look like at the bedside? Robin walks through real data, real constraints, and what she sees as the next stage of AI in acute care.

💬 How are you approaching sepsis detection in your organization today? What has helped and what still gets in the way? Share your perspective in the comments.

🔔 Subscribe for more great interviews with Health IT leaders.

Learn more about Prenosis at https://prenosis.com/

Find more great health IT content at https://www.healthcareittoday.com/